2. Human Mixtard Brand Of NOVO NORDISK Denmark based company. Indication in case of Diabetes Mellitus. Human Mixtard contains Premixed Human Insulin.(30:70 & 50:50) 30% Regular Insulin & 70% NPH Insulin. 50% Regular Insulin & 50% NPH Insulin Its available as Human Mixtard 30 and Human Mixtard 50.
3. NOVO NORDISK Market Leader in the Diabetic Segment. Only Company having all the range of Insulin. REGULAR INSULIN (ACTRAPID) NPH INSULIN (INSULATARD) PREMIXED INSULIN (HUMAN MIXTARD 30 & 50) LONG ACTING DETIMIR INSULIN (LEVIMIR) RAPID ACTING ASPART INSULIN (NOVORAPID) PREMIXED ASPART INSULIN (NOVOMIX)
4. DEVICES AVAILABLE Available in the form of Vials, Pens. The Pens are also of 2 types, Prefilled Pens (Novolet) and Durable Pens (Novo Pen 3 and 4). Vials are available in 40IU (10ml), where as the Pen fills are available in 100IU (3ml).
10. PRICE HUMAN MIXTARD 30 VIAL-Rs.158 HUMAN MIXTARD PEN FILLS-Rs.1040 (Pack of 5) NOVO PEN 3 –Rs.600 NOVOLET PEN (PREFILLED PEN)-Rs.300
11. COLLABORATIONS Torrent Manufactures Human Mixtard Vials at their Ahmadabad unit (Same Quality). Abott handles the Distribution of all the Insulins of Novo Nordisk. The Pens and the Pen fills are Manufactured in Denmark and are Imported to India.
12. COMPETITORS HUMINSULIN (ELI LILLY) WOSULIN (WOCKHARDT) LUPISULIN (LUPIN) INSUGEN (BIOCON) RECOSULIN (SHREYA LIFE SCIENCE) INSUMAN (SANOFI AVENTIS) INSUCARE (RANBAXY)
13. MARKET SHARE Insulin & its analogs market in 2008 was USD12.25 Bn. NOVO NORDISK today holds 65% Market Share Globally in Insulin segment. They are the Market Leaders in Insulin Segment. Presence in 52 Countries. 5TH LARGEST SELLING BRAND IN INDIA in May-2009. Annual sales in 2009 was Rs.123.54 Cr. Market Share of 0.34%, Growing at 1.6%
17. CURRENT STRATERGY QUALITY of Insulin. Focusing on the Fetures of Pens. Patient Services. Free Demo to the patients at their door step. Free Pens to needy Patients. Complete Range of Insulins available Availability:- Freely Available
18. Why Drs Prefer Human Mixtard ? Brand Image. Availability. Presence in 52 countries, so widely accepted by all the Drs world wide. Provides News articles and other Diabetes related news to the Drs. Other New molecule’s CMEs.
